During the past decade, Retina Northwest, PC conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 23 clinical trials were completed, i.e. on average, 67.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 18 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Northwest, PC" #1 sponsor was "Jaeb Center for Health Research" with 17 trials, followed by "Hoffmann-La Roche" with 13 trials sponsored, "Kodiak Sciences Inc" with 4 trials sponsored, "Apellis Pharmaceuticals, Inc." with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Northwest, PC" #1 collaborator was "National Eye Institute (NEI)" with 18 trials as a collaborator, "National Institutes of Health (NIH)" with 6 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 5 trials as a collaborator and "Allergan" with 4 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Retina Northwest, PC" are "Diabetic Macular Edema" (16 trials), "Geographic Atrophy" (5 trials), "Macular Degeneration" (5 trials), "Diabetic Retinopathy" (4 trials) and "Proliferative Diabetic Retinopathy" (4 trials). Many other conditions were trialed in "Retina Northwest, PC" in a lesser frequency.

Most popular intervention types in "Retina Northwest, PC" are "Drug" (42 trials), "Other" (11 trials), "Procedure" (11 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (12 trials), "Faricimab" (8 trials), "Aflibercept" (7 trials), "Ranibizumab" (6 trials) and "KSI-301" (4 trials). Other intervention names were less common.

The vast majority of trials in "Retina Northwest, PC" are 49 trials for "All" genders.

Currently, there are NaN active trials in "Retina Northwest, PC". undefined are not yet recruiting, 1 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Retina Northwest, PC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Northwest, PC, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".